Tools for GPCR drug discovery

被引:0
|
作者
Ru Zhang
Xin Xie
机构
[1] Shanghai Key Laboratory of Signaling and Disease Research,
[2] Laboratory of Receptor-based Bio-medicine,undefined
[3] School of Life Sciences and Technology,undefined
[4] Tongji University,undefined
[5] State Key Laboratory of Drug Research,undefined
[6] the National Center for Drug Screening,undefined
[7] Shanghai Institute of Materia Medica,undefined
[8] Chinese Academy of Sciences,undefined
来源
Acta Pharmacologica Sinica | 2012年 / 33卷
关键词
G-protein-coupled receptors (GPCRs); high-throughput screening; high-content screening; functional assay; G-protein-dependent assay; G-protein-independent assay; label-free assay; functional selectivity;
D O I
暂无
中图分类号
学科分类号
摘要
G-protein-coupled receptors (GPCRs) mediate many important physiological functions and are considered as one of the most successful therapeutic targets for a broad spectrum of diseases. The design and implementation of high-throughput GPCR assays that allow the cost-effective screening of large compound libraries to identify novel drug candidates are critical in early drug discovery. Early functional GPCR assays depend primarily on the measurement of G-protein-mediated 2nd messenger generation. Taking advantage of the continuously deepening understanding of GPCR signal transduction, many G-protein-independent pathways are utilized to detect the activity of GPCRs, and may provide additional information on functional selectivity of candidate compounds. With the combination of automated imaging systems and label-free detection systems, such assays are now suitable for high-throughput screening (HTS). In this review, we summarize the most widely used GPCR assays and recent advances in HTS technologies for GPCR drug discovery.
引用
收藏
页码:372 / 384
页数:12
相关论文
共 50 条
  • [1] Tools for GPCR drug discovery
    Zhang, Ru
    Xie, Xin
    ACTA PHARMACOLOGICA SINICA, 2012, 33 (03) : 372 - 384
  • [2] DRUG DISCOVERY Takeda taps Sosei for GPCR drug discovery
    Cross, Ryan
    CHEMICAL & ENGINEERING NEWS, 2019, 97 (32) : 15 - 15
  • [3] Nanobodies and their Use in GPCR Drug Discovery
    Cromie, Karen D.
    Van Heeke, Gino
    Boutton, Carlo
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2015, 15 (24) : 2543 - 2557
  • [4] cAMP assays in GPCR drug discovery
    Vasudevan, Neelakantan T.
    G PROTEIN-COUPLED RECEPTORS, 2ND EDITION, PT A, 2017, 142 : 51 - 57
  • [5] New paradigms in GPCR drug discovery
    Jacobson, Kenneth A.
    BIOCHEMICAL PHARMACOLOGY, 2015, 98 (04) : 541 - 555
  • [6] New Paradigms in GPCR Drug Discovery
    Dorange, Ismet
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2015, 15 (24) : 2475 - 2475
  • [7] Impact of GPCR Structures on Drug Discovery
    Congreve, Miles
    de Graaf, Chris
    Swain, Nigel A.
    Tate, Christopher G.
    CELL, 2020, 181 (01) : 81 - 91
  • [8] Conotoxins - Blueprints for GPCR drug discovery?
    Muttenthaler, M.
    Gruber, C. W.
    Andersson, A.
    Vetter, I.
    Nevin, S. T.
    Grishin, A. A.
    Dutertre, S.
    Daly, N. L.
    Craik, D. J.
    Adams, D. J.
    Lewis, R. J.
    Alewood, P. F.
    BIOPOLYMERS, 2011, 96 (04) : 422 - 422
  • [9] GPCR-targeted drug discovery
    Xie, X.
    PLANTA MEDICA, 2019, 85 (18) : 1405 - 1405
  • [10] Variation in GPCR signaling: Implications for drug discovery
    Babu, Madan
    BIOPHYSICAL REVIEWS, 2021, 13 (06) : 1505 - 1506